← Open Payments lookup

TAKESHIA NIDAY: Open Payments

NPI 1932429289 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,291 in 60 payments from 12 companies in 2025. Trend: 2023 $839 · 2024 $1,966 · 2025 $2,291

Food & beverage: $2,291
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.11$523
Alkermes, Inc.6$346
Otsuka America Pharmaceutical, Inc.11$325
Teva Pharmaceuticals USA, Inc.6$292
E.R. Squibb & Sons, L.L.C.4$214
SUN PHARMACEUTICAL INDUSTRIES INC.6$170
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$121
ABBVIE INC.3$84
Lundbeck LLC3$76
Janssen Pharmaceuticals, Inc2$60

Products named: INGREZZA, REXULTI, ARISTADA, COBENFY, UZEDY, LYBALVI, CAPLYTA, AUSTEDO XR.

Industry payments across CA — which companies pay providers there.